Stocks
Intercept Pharmaceuticals (ICPT) EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -278.7 | -303.5 | -212.2 | -53.6 | -61.7 | -41.7 | ||
| Changes by years, y/y, % | -15% | +9% | -30% | -75% | +15% | -28.3% | |||
Intercept Pharmaceuticals. EBITDA US GAAP, bln rub
Intercept Pharmaceuticals. EBITDA US GAAP, changes, %
Intercept Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Intercept Pharmaceuticals (ICPT) EBITDA US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -7.65 | -14.7 | -29.1 | -3.01 | 5.15 | -41.7 | |
| Changes by years, y/y, % | -172% | -88% | +184% | -79% | -167% | |||
| Changes by quarters, q/q, % | -47% | +93% | +97% | -90% | -271% | |||
